Free Trial
OTCMKTS:NUMIF

Numinus Wellness (NUMIF) Stock Price, News & Analysis

Numinus Wellness logo
C$0.02 0.00 (-12.00%)
As of 05/1/2025 03:47 PM Eastern

About Numinus Wellness Stock (OTCMKTS:NUMIF)

Key Stats

Today's Range
C$0.02
C$0.03
50-Day Range
C$0.02
C$0.04
52-Week Range
C$0.01
C$0.08
Volume
111,675 shs
Average Volume
88,530 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Numinus Wellness Inc. provides psychedelic-assisted psychotherapy products and services in Canada and the United States. The company operates through Clinical Research Operations, Canadian Clinic Network, and U.S Clinic Network segments. The Clinical Research Operations segment offers clinical research management services to academic institutions and biotechnology companies. The Canadian Clinic Network segment provides clinical services, including traditional therapy and counseling, ketamine-assisted therapies for depression, psychedelic-assisted therapies, mindfulness programs, and virtual psychotherapy services, as well as neurological care services. The US clinic network segment offers psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management services. The company also offers laboratory services, such as the cultivation, production, and extraction of natural Psilocybe and other psychoactive fungi species, the development of proprietary processes and products, methods for controlled psychedelics and development of a pipeline for product development, and protocol development and safety and efficacy studies; lab testing services; and psychedelic-assisted therapy training services. The company was incorporated in 1964 and is headquartered in Vancouver, Canada.

Receive NUMIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Numinus Wellness and its competitors with MarketBeat's FREE daily newsletter.

NUMIF Stock News Headlines

Numinus Wellness announces CFO transition
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Numinus Wellness Inc. Announces CFO Transition
See More Headlines

NUMIF Stock Analysis - Frequently Asked Questions

Numinus Wellness' stock was trading at C$0.03 at the beginning of 2025. Since then, NUMIF shares have decreased by 12.0% and is now trading at C$0.02.
View the best growth stocks for 2025 here
.

Shares of NUMIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
N/A
Current Symbol
OTCMKTS:NUMIF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:NUMIF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners